Hillsdale Investment Management Inc.
Position in HRMY — Harmony Biosciences Holdings, Inc.
CIK 1368465
Toronto, A6
Position in HRMY
as of Mar 31, 2026
· filed May 4, 2026
Position Value
$3,848,574
-$1,292,934 QoQ
Shares Held
137,400
0.0% QoQ
Ownership
0.236%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2022
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HRMY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Hillsdale Investment Management Inc. holds $115,919,445 across 23 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AXSM |
Axsome Therapeutics, Inc.
|
55,000 | $13,462,350 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
169,112 | $12,595,461 | |
| 3 | MRVI |
Maravai Lifesciences Holdings, Inc.
|
1,682,878 | $10,501,158 | |
| 4 | ZYME |
Zymeworks Inc.
|
382,922 | $10,009,581 | |
| 5 | TVTX |
Travere Therapeutics, Inc.
|
167,900 | $9,538,399 | |
| 6 | AUPH |
Aurinia Pharmaceuticals Inc.
|
550,900 | $9,348,773 | |
| 7 | MIRM |
Mirum Pharmaceuticals, Inc.
|
58,630 | $6,863,814 | |
| 8 | ENTA |
Enanta Pharmaceuticals Inc
|
468,000 | $6,823,440 |
All Filings in HRMY
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,848,574 | 137,400 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $5,141,508 | 137,400 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $3,786,744 | 137,400 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $3,814,120 | 120,700 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $2,329,938 | 70,200 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $2,339,880 | 68,000 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $2,708,000 | 67,700 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $2,015,356 | 66,800 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $2,337,168 | 69,600 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $2,063,970 | 63,900 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $2,103,834 | 64,200 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $2,259,198 | 64,200 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $2,468,340 | 75,600 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $4,165,560 | 75,600 | Shares | Sole | 2023-02-13 | |
| No filing history on record for this holder in this stock. | ||||||